[1
]
From the Department of Neonatology, University Hospital Zurich, University of Zurich,
Zurich (D.B.), and the Department of Pediatric Pharmacology, University Children's
Hospital, Basel (J.N.A.) - both in Switzerland; the Department of Neonatology (D.B.,
C.F.P.) and the Center for Pediatric Clinical Studies (C.E.), University Children's
Hospital Tübingen, and the Institute for Clinical Epidemiology and Applied Biometry
(C.M.) and the Department of Clinical Pharmacology (M.S.), University Hospital Tübingen,
Tübingen, and Dr. Margarete Fischer Bosch Institute of Clinical Pharmacology, Stuttgart
(M.S.) - all in Germany; Charles University, General University Hospital and First
Faculty of Medicine, Prague, Czech Republic (R.P.); Ziv Medical Center, Zefat, Bar-Ilan
University, Ramat Gan, Israel (E.S.S.); the Department of Pediatrics, Oulu University
Hospital and University of Oulu, Oulu, Finland (M.H.); Assistance Publique-Hôpitaux
de Paris, Département Hospitalo-Universitaire, Université Paris Descartes, Hôpital
Cochin, Service de Médecine et Réanimation néonatales de Port-Royal, Paris (P.-H.J.);
Polytechnic University of Marche, Salesi Children's Hospital, Ancona, Italy (V.C.);
the Division of Pediatric Clinical Pharmacology, Children's National Medical Center,
Washington, DC (J.N.A.); Intensive Care and Department of Pediatric Surgery, Erasmus
Medical Center-Sophia Children's Hospital, Rotterdam, the Netherlands (J.N.A.); and
the Department of Child Health at Queen's University Belfast, Institute of Clinical
Science, Belfast, Northern Ireland (H.L.H.).
